Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03242343 · ClinicalTrials.gov registry record · NA
VasQ External Support for Arteriovenous Fistula
A NA study, sponsored by Laminate Medical Technologies.
- Completed
- Registry status
- NA
- Development phase
- 144
- Enrollment target
NCT03242343: Completed NA study, sponsored by Laminate Medical Technologies.
NCT03242343 is a NA study that has completed, run by Laminate Medical Technologies. The registered enrollment target is 144 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03242343, a NA study, has completed, sponsored by Laminate Medical Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
Study Summary
This is a prospective clinical study of the VasQ external support for arteriovenous fistulas. The device is designed to improve fistula outcomes by optimizing the geometrical configuration of the fistula, influencing hemodynamics, minimizing turbulence and promote laminar flow. All patients will be implanted with the VasQ device and will be followed up for a duration of 24 months.
Primary Outcome
Proportion of patients with freedom from intervention since device placement
Interventions
- DEVICE VasQ
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2017-11-29 |
| Est. Completion | 2022-04-03 |
| Phase | NA |
What the finished NCT03242343 record still lists
NCT03242343 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which VasQ is the first listed.
NCT03242343 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03242343 about?
NCT03242343 is a clinical study titled "VasQ External Support for Arteriovenous Fistula". This is a prospective clinical study of the VasQ external support for arteriovenous fistulas. The device is designed to improve fistula outcomes by optimizing the geometrical configuration of the fistula, influencing hemodynamics, minimizing turbulence and promote laminar flow. All patients will be...
What is the current status of trial NCT03242343?
This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2017-11-29. Estimated completion is 2022-04-03.
What interventions are being tested in trial NCT03242343?
The interventions under investigation include: VasQ (DEVICE).
Who is sponsoring clinical trial NCT03242343?
This trial is sponsored by Laminate Medical Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03242343's enrollment target sits among peer trials
144 706th of 2000 higher than 1,290 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI